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The reactive response of brain tissue to implantable intracortical microelectrodes is
thought to negatively affect their recordable signal quality and impedance, resulting in
unreliable longitudinal performance. The relationship between the progression of the
reactive tissue into a glial scar and the decline in device performance is unclear. We
show that exposure to a model protein solution in vitro and acute implantation result
in both resistive and capacitive changes to electrode impedance, rather than purely
resistive changes. We also show that applying 4000 MW polyethylene glycol (PEG)
prevents impedance increases in vitro, and reduces the percent change in impedance
in vivo following implantation. Our results highlight the importance of considering
the contributions of non-cellular components to the decline in neural microelectrode
performance, and present a proof of concept for using a simple dip-coated PEG film to
modulate changes in microelectrode impedance.
Keywords: intracortical microelectrodes, foreign-body reaction, impedance spectroscopy, polyethylene glycols, dip
coating
INTRODUCTION
Failure of intracortical microelectrodes typically manifests as
increased impedance and decreased signal to noise ratio, and is
thought to be associated with the formation of a dense glial scar
and loss of neuronal density. In vivo impedance monitoring is a
common tool to assess the functionality of implanted intracortical
microelectrodes, and has been used to infer the progression of
the reactive tissue response to implanted intracortical microelec-
trodes (Williams et al., 1999, 2007; Vetter et al., 2004). Recent
research shows that changes in electrical properties monitored
by impedance spectroscopy do not always perfectly correlate with
cellular responses (Prasad et al., 2012; Prasad and Sanchez, 2012),
implicating additional biotic and abiotic factors. In vitro testing
in 3D gel constructs reveal that different glial cells adhered to
the surface of a microelectrode have different impedance profiles
(Frampton et al., 2010). One factor that has not been well investi-
gated is the adsorption of proteins and other biomolecules. While
adsorbed proteins have been implicated in the biological response
(Leung et al., 2008), their effects on the electrical impedance of
intracortical microelectrodes have not been previously described
with impedance spectroscopy. Prevalent electrical circuit models
of the tissue electrode interface assume that adsorbed proteins
result in purely resistive impedance changes (Johnson et al., 2005;
Otto et al., 2006; Williams et al., 2007), but there is not sufficient
empirical verification of this assumption. To the best of the
authors’ knowledge, there are no reports in the literature on the
effects of adsorbed proteins or non-cellular components on the
impedance of intracortical microelectrodes.
Another aspect to the problem of biomolecule adsorption
is the question of preventing detrimental changes to the elec-
trical characteristics of intracortical microelectrodes using sim-
ple and cost effective approaches. For implantable devices in
other biological systems, protein-resistant or anti-fouling treat-
ments are commonplace (Salacinski et al., 2001; Bluestein et al.,
2010; Li and Henry, 2011). One of the most common materials
used to enhance the biocompatibility of biomedical implants is
polyethylene glycol (PEG). Due to its hydrophilic nature, PEG
prevents the adsorption of proteins by reducing access to the more
hydrophobic surface onto which proteins prefer to bind (Michel
et al., 2005). Typically, PEG is chemically grafted onto a substrate
and reliably reduces protein adsorption (Sharma et al., 2004a,b;
Muthusubramaniam et al., 2011). In the context of intracortical
microelectrodes, PEG has traditionally been used as a scaffold for
thick drug eluting hydrogels (Winter et al., 2007; Rao et al., 2012),
the size scale of which might exacerbate neuronal displacement.
Thinner conformal microgel coatings which incorporate PEG as
a cross linker have been investigated, but do not significantly
improve the chronic tissue response (Gutowski et al., 2014).
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Free-floating PEG injected intravenously has been reported to
improve cellular and behavioral recovery following traumatic
brain injury (Koob et al., 2005, 2008; Koob and Borgens, 2006).
Because of the complexity of the reactive tissue response of the
brain to implanted microelectrodes, and the fact that the cause
of the majority of chronic microelectrode failures are unknown
(Barrese et al., 2013), the long-term effects of a simply applied
anti-fouling coating on the tissue response cannot be confidently
predicted. In the short-term, however, it is possible that such a
simply applied anti-fouling coating might improve the electrical
properties of acutely implanted neural microelectrodes, which, in
turn, might improve the accuracy of impedance monitoring as
a predictive tool for the progression of the tissue response. The
authors are not aware of any reports in the literature that examine
the effects of a simple dip-coated PEG film on the electrical
properties of neural microelectrodes under acute in vitro or in vivo
settings.
The primary objective of this paper is to quantify the acute
effects on microelectrode impedance of adsorbed proteins in vitro,
and non-cellular molecular components in vivo. A secondary
objective is to present a proof of concept on the use of an aqueous
dip-coated PEG film in preventing impedance changes to neural
microelectrodes during acute timescales. For this proof of concept
experiment, a molecular weight of 4000 Da was chosen according
to literature reports demonstrating optimal antifouling properties
at this molecular weight (Su et al., 2009). We first present an
analysis of changes in intracortical microelectrode impedance
following immersion in a model protein solution mimicking in
vivo brain protein concentration. Total impedance, resistance, and
reactance are analyzed at different frequency values to quantify
the contribution of adsorbed proteins to the impedance changes
affecting electrode performance. We show that a dip-coated film
of a relatively high molecular weight PEG prevents changes in
impedance upon immersion in protein solution. We then demon-
strate in an acute in vivo experiment that increases in microelec-
trode impedance after insertion into the cortex can be reduced
by applying the same PEG treatment to the electrode shank and
implantation site.
MATERIALS AND METHODS
IN VITRO STUDY WITH MODEL PROTEIN SOLUTION
Electrochemical measurements of 16-channel single shank Michi-
gan electrode arrays (CNCT, Ann Arbor, MI) were made using
an Autolab potentiostat PG-STAT12 with a built-in frequency
response analyzer (EcoChemie, Utrecht, The Netherlands). For
this study, a three-electrode cell configuration was used with
the microelectrode site functioning as the working electrode, a
large-area Pt wire functioning as the counter electrode, and an
Accumet, gel-filled, KCl saturated calomel electrode (Thermo
Fischer Scientific, Fair Lawn, NJ) functioning as the reference
electrode. This three-electrode setup was chosen for this study
because of its ability to isolate the electrode/solution interface
impedance component.
For each electrode array, cyclic voltammetry (CV) was per-
formed by sweeping the applied voltage from −0.6 to +0.8 V
at a scanning rate of 1 V/s to determine sites with broken or
poor connections, designated as those sites exhibiting a maximum
current below 1 nA. These sites were discarded from the analysis,
thus yielding a total of 30 functional sites on three different
electrode arrays.
Electrochemical impedance spectroscopy (EIS), using the
PGSTAT12, was used to measure the impedance of the electrode
sites with the application of 15 sequentially applied sinusoidal
waves at logarithmically spaced frequencies ranging from 46 Hz
to 10 kHz, with an amplitude of 25 mVRMS. For each electrode,
impedance spectroscopy was performed in PBS following each of
three different treatments: (a) no treatment; (b) immersion in a
10% solution of bovine serum albumin (BSA) (Sigma-Aldrich,
St. Louis, MO) in PBS, the concentration of which was chosen
to mimic protein concentration in rat cerebral cortex (Banay-
Schwartz et al., 1992); and (c) immersion in a 20% solution of
4000 MW PEG (Alfa-Aesar, Ward Hill, MA), air-drying for 1 min,
then immersion in BSA. Immersion and subsequent removal from
the described solutions was done at a controlled velocity using
a micro-manipulator. An additional volume of 100 µl of PEG
was further applied directly onto the microelectrode shank as it
was immersed in BSA to mimic a topical application. Electrodes
were rinsed with deionized water and anodically cleaned between
the different treatments using 10-s long DC pulses, as described
previously (Sommakia et al., 2009). Bode and Nyquist plots were
generated for all treatment groups. Comparisons of the resistance,
reactance and total impedance were done at 50 Hz, 100 Hz, 1 kHz,
and 10 kHz.
ACUTE IN VIVO STUDY
The laboratory animal protocol for this work was approved
through the Purdue Animal Care and Use Committee (West
Lafayette, IN, USA), and conforms to the guidelines of the US
National Institutes of Health. Three Sprague Dawley rats (Harlan
Laboratories, Indianapolis, IN) were used for this study. Each
rat was anesthetized with 2% isofluorane, then transferred to
a stereotactic frame and maintained with 0.5–1% isofluorane
delivered through a nose cone. The head was shaved and swabbed
with alternating washes of betadine and alcohol, and an eye lubri-
cating ointment applied. Lidocaine was injected subcutaneously
at multiple positions in the head, and then a midline incision
approximately 2 cm long was made along the cranium with a
scalpel. The underlying pericranium was removed to expose the
skull. A single burr hole was made with a dental drill towards the
back of the head, slightly anterior to the ears, and a stainless steel
bone screw attached to a segment of platinum wire was threaded
into it to serve as a counter electrode. Bilateral craniotomies about
2.5 mm in diameter were made with a dental drill, approximately
2.5 mm anterior to Bregma and 2 mm lateral to the midline.
For each craniotomy, a slit was made in the dura using surgical
microscissors. One craniotomy serving as a control was wetted
with 0.9% sterile saline before electrode insertion, while the other
craniotomy was wetted with 20% w/v solution of 4000 MW PEG
in MilliQ water prior to electrode insertion.
16-channel single-shank Michigan probes were also used for
this study. Because of the difficulty of achieving a three-electrode
setup in a surgical setting, a two-electrode setup was chosen
instead. Prior to insertion into the cortex, baseline impedance
was established in vitro by performing the same EIS procedure
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described above, but in a two-electrode setup. The electrode was
then manually inserted into the exposed cortex of the control
craniotomy using a magnet-stabilized micromanipulator, and EIS
was measured 5 min after insertion. The electrode was then
removed, rinsed with MilliQ water, and cleaned by applying a DC
bias of 1.5 V for 10 s in PBS, as described previously (Sommakia
et al., 2009). After verifying the return of the 1 kHz impedance
to baseline, the electrode was dip-coated at a controlled velocity
using a micromanipulator in a 20% solution of 4000 MW PEG
in MilliQ water for 1 min and allowed to dry for 2 min. The
PEG-coated electrode was then inserted using the micromanip-
ulator into the other craniotomy wetted with PEG, and EIS was
performed again.
STATISTICAL ANALYSIS
Statistical analysis was performed using the SAS 9.3 statistical
package (SAS Institute, Cary, NC). A general linear model (GLM)
procedure was used to perform a one way ANOVA with block
to remove variations between the different electrodes by treating
electrodes as a statistical block. Tukey post-hoc tests were used to
identify statistically significant differences between the groups at a
significance level of α = 0.05. Plots were generated using MATLAB
(The MathWorks Inc., Natick, MA).
RESULTS
ANALYSIS OF IMPEDANCE CHANGES WITH MODEL PROTEIN
SOLUTION AND PEG IN VITRO
An examination of Bode plots reveals that the gain for electrodes
immersed into is higher than for uncoated controls for all fre-
quencies, indicating an overall increase in impedance. Electrodes
treated with PEG prior to BSA immersion show more congruence
with the gain of uncoated electrodes (Figure 1A). The phase
for non-PEG treated electrodes immersed in BSA exhibits lower
angles at the lower end of the frequency spectrum, and the
difference is most pronounced in the middle of the spectrum
between 200–500 Hz (Figure 1B). In Figure 2, the Nyquist plot
for non-PEG treated electrodes immersed in BSA reveal a shift up
and the right compared to the controls, indicating both increased
resistance and reactance, with the most pronounced divergence
occurring toward the middle of the plot. In contrast, the plot
for electrodes pretreated with PEG shows more congruence with
uncoated controls in the middle of the plot and slight divergence
at the lower end of the plot, corresponding to the higher frequen-
cies. To better understand the details of these changes and their
potential implication for mitigation attempts, we examined the
percent changes in resistance, reactance, and total impedance at
various points across the frequency spectrum.
Figure 3A shows percent changes in the real component of the
impedance, i.e., resistance, relative to the control at four frequency
values across the spectrum. Electrodes immersed in BSA without
PEG pretreatment exhibited statistically significant increases in
the resistance compared to the uncoated control at examined fre-
quencies. The highest resistance increase relative to control was in
the middle of the frequency spectrum, specifically at 1 kHz, with
a 30.7% increase in resistance. At 50 Hz, the increase in resistance
for the BSA coated electrodes without PEG pretreatment was
14.5%, at 100 Hz, the resistance increase was 23.9%, and 10 kHz,
the resistance increase was 17%. The electrodes pretreated with
PEG prior to BSA immersion, on the other hand, did not exhibit
any significant differences in resistance compared to the uncoated
controls at all examined frequencies.
Figure 3B shows percent changes in the imaginary component
of the impedance, i.e., reactance, relative to the control at four
frequency values. For electrodes not pretreated with PEG prior
to immersion in BSA, no significant increase in reactance was
observed at 50 Hz or 100 Hz, while increases of 12% and 15% were
observed at 1 kHz and 10 kHz, respectively. In contrast, electrodes
pretreated with PEG prior to immersion in BSA exhibited modest
decreases in the reactance relative to control at all frequencies
(−6.3% at 50 Hz, −6.3% at 100 Hz, −4.2 at 1 kHz, and −4.8% at
10 kHz). Figure 3C shows the percent changes in total impedance
relative to the control at four frequency values. For electrodes
not pretreated with PEG prior to BSA immersion, no significant
difference in total impedance was observed at 50 Hz, but pro-
gressive increases in the impedance were observed at the higher
frequencies (4.5% at 100 Hz, 13.5% at 1 kHz, 15.3% at 10 kHz).
For electrodes pretreated with PEG prior to BSA immersion,
modest decreases in total impedance were observed at the lower
frequencies (−5.8% at 50 Hz, −5.6% at 100 Hz, −3.9 at 1 kHz),
while no significant difference in the total impedance compared
to the control was observed 10 kHz.
ANALYSIS OF IMPEDANCE CHANGES IN VIVO WITH AND
WITHOUT PEG
Figure 4A shows the percent increase of the real compo-
nent of the impedance, i.e., resistance, between the in vitro
baseline and the in vivo measurement at four frequency val-
ues across the spectrum. In both cases of no treatment and
PEG treatment, the resistance exhibited a significant increase
when measured in vivo compared to the in vitro baseline.
Insertion into the cortex without PEG treatment, however,
resulted in a larger increase from the in vitro baseline at
all frequencies compared to insertion with PEG treatment.
The percent change in resistance was also frequency-dependent.
For the no treatment condition, the percent increase from baseline
was as follows: 71.8 ± 2.99% at 50 Hz, 89.8 ± 3.77% at 100 Hz,
209.5 ± 9.1% at 1 kHz, and 290.5 ± 13.7% at 10 kHz; while for
the PEG treatment condition, the percent increase from baseline
was: 44.6 ± 3% at 50 Hz, 58 ± 3.9% at 100 Hz, 149.5 ± 9.3%
at 1 kHz, and 223.3 ± 14% at 10 kHz. The percent increase
in resistance from baseline for the no treatment condition was
significantly different from the percent increase in resistance from
baseline for the PEG treatment at all frequencies.
Figure 4B shows the percent increase of the imaginary com-
ponent of the impedance, i.e., reactance, between the in vitro
baseline and the in vivo measurement at four frequency values
across the spectrum. In both cases of PEG treatment or no
treatment, the reactance increased significantly when measured
in vivo compared to the in vitro baseline. Insertion into the cortex
without PEG treatment, however, resulted in a larger increase
in reactance from baseline compared to insertion with PEG
treatment. The percent change in reactance was also frequency-
dependent. For the no treatment condition, the percent increase
from baseline was as follows: 45.4 ± 1.6% at 50 Hz, 48.1 ± 2%
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FIGURE 1 | Bode plots. (A) For electrodes immersed in BSA with no PEG
coating, the total impedance magnitude plot is higher than the control, while
electrodes coated with PEG prior to BSA immersion show an impedance
magnitude plot indistinguishable from control. (B) Electrodes immersed in
BSA with no PEG coating show lower phase angles at lower and intermediate
frequencies compared to the control, while the phase angle for electrodes
coated with PEG prior to immersion in BSA exhibit smaller phase angles at all
frequencies.
FIGURE 2 | Nyquist plot for electrodes pretreated with PEG prior to
immersion in BSA is close to the control plot, with a slight shift to the
left at lower frequencies, indicating a decrease in resistance. Nyquist
plot for electrodes not pretreated with PEG before BSA shows a shift up
and to the right, indicating increases in both resistance and reactance.
at 100 Hz, 66.4 ± 2.3% at 1 kHz, and 146.8 ± 6.2% at 10 kHz;
while for the PEG treatment condition, the percent increase from
baseline was: 30.8 ± 1.6% at 50 Hz, 31.4 ± 2% at 100 Hz, 41 ±
2.4% at 1 kHz, and 97.1 ± 6.4% at 10 kHz. The percent increase
in reactance from baseline for the no treatment condition was
significantly different from the percent increase in resistance from
baseline for the PEG treatment at all frequencies. The amount of
percent change in reactance is lower than the amount of percent
change in resistance at each respective frequency. Figure 4C shows
the percent increase in total impedance between the in vitro
baseline and in vivo measurement at four frequency values across
the spectrum. In both cases of PEG treatment or no treatment,
the total impedance increased significantly when measured in vivo
compared to the in vitro baseline. Insertion into the cortex with-
out PEG treatment, however, resulted in a larger increase from
baseline compared to insertion with PEG treatment. The percent
change in total impedance was also frequency-dependent. For the
no treatment condition, the percent increase in total impedance
from baseline was as follows: 47.4 ± 1.7% at 50 Hz, 52.2 ± 2.1%
at 100 Hz, 88.62 ± 2.9% at 1 kHz, and 214.5 ± 9.8% at 10 kHz;
while for the PEG treatment condition, the percent increase in
total impedance from baseline was: 33.6 ± 1.6% at 50 Hz, 33.5 ±
2.1% at 100 Hz, 57.1 ± 3% at 1 kHz, and 162 ± 10% at 10 kHz.
The percent increase in total impedance from baseline for the no
treatment condition was significantly different from the percent
increase in total impedance from baseline for the PEG treatment
at all frequencies.
DISCUSSION
RATIONALE
The prevalent narrative in the literature suggests that the in vivo
reactive tissue response is an aggregate of amplified biological
processes that begin with device insertion and accompanying
trauma. The indwelling implant acts as a sink for various proin-
flammatory proteins, as well as a substrate for cell attachment
(Leung et al., 2008). To the best of the authors’ knowledge, the
impedance changes resulting from protein adhesion onto neural
microelectrodes have not been previously quantified, nor have
the effects of anti-fouling treatments on impedance of neural
microelectrodes. Most current efforts towards mitigating the
reactive tissue response focus on targeting and quantifying the
cellular component of the reactive tissue response. Recent find-
ings, however, indicate that strong cellular responses to implanted
microelectrodes do not necessarily correspond to similar changes
in electrode impedance (Prasad and Sanchez, 2012). We posit that
extracellular components of the reactive tissue response might
be more instrumental in altering the electrical properties of
implanted electrodes, and thus offer an attractive alternative for
quantification and mitigation. The primary objective of this paper
was to identify non-cellular components as potential modulators
of impedance changes in neural microelectrodes, and to quantify
the effects of a specific type of non-cellular component in vitro
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FIGURE 3 | Changes in electrode impedance following immersion in
BSA, without and with PEG treatment. (A) Resistance of electrodes
immersed in BSA with no PEG treatment exhibits significant increases
compared to control at all observed frequencies, notably an increase in
resistance of 30.7% compared to control at 1 kHz. Electrodes treated with
PEG prior to immersion in BSA exhibit no significant changes in resistance
compared to control. (B) Reactance of electrodes immersed in BSA with no
PEG treatment exhibit significant increases at frequencies greater than 50 Hz,
with the highest increase observed at 10 kHz. PEG treatment prior to
immersion in BSA resulted in minor, but significant decreases at frequencies
greater than 50 Hz. (C) Changes in total impedance closely match changes in
reactance. Error bars represent the standard error of the means. Single
asterisks (*) respresent p < 0.05, double asterisks (**) represent p < 0.001,
triple asterisks (***) represent p < 0.0001.
(proteins). The secondary objective was to demonstrate a proof
of concept at acute time scales for using PEG applied via a simple
dip-coating process to prevent impedance changes caused by non-
cellular components both in vitro and in vivo.
EXPLANATION OF RESULTS
For the in vitro study with the model protein solution, a
three-electrode setup was chosen for its ability to isolate the
electrode/solution interface impedance. Changes in impedance
measured using this three-electrode setup indicate changes only
at the electrode/solution interface (Bard and Faulkner, 2001).
Because of the combination of low currents, short timescales,
micro-scale working electrodes, and a large area counter, it was
assumed that very minimal changes could have occurred at the
recording surface. Using this measurement paradigm, our first
finding was that significant increases in resistance at all examined
frequencies occur immediately upon exposure to a model protein
solution with a concentration mimicking in vivo concentrations.
Furthermore, significant increases in the reactance are observed at
higher frequencies, including the physiologically relevant 1 kHz.
The aggregate impedance effect is that of a significant increase at
frequencies higher than 50 Hz. These observed in vitro changes
in impedance might not exactly match in vivo changes, given
the difference in protein composition in the brain, and the pres-
ence of additional biomolecules with widely varying degrees of
hydrophobicity, such as lipids and polysaccharides (O’Brien and
Sampson, 1965; Pease, 1966; Margolis and Margolis, 1974; Norton
et al., 1975). This finding of changes in both resistive and capaci-
tive components following protein adsorption challenges current
assumptions inherent in prevalent electrical circuit models of the
device tissue interface. Such models typically assume that protein
adsorption causes purely resistive changes in impedance (Johnson
et al., 2005; Otto et al., 2006; Williams et al., 2007). We demon-
strate that the exposure of microelectrodes to a protein solution
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FIGURE 4 | In vivo increase in resistance (A), reactance (B), and total
impedance (C) from in vitro baseline, with and without PEG treatment.
For either treatment condition, a significant increase in impedance (both
resistance and reactance) from the in vitro baseline is observed at all
frequencies (p < 0.05). For electrodes with no treatment, the percent
increase in impedance (both resistance and reactance) from baseline was
significantly higher (p < 0.05) than the percent increase with PEG treatment
at all frequencies.
results in both resistive and capacitive changes in impedance,
rather than purely resistive changes. These findings suggest a
need for the reexamination of assumptions upon which prevalent
electrical circuit models for the tissue electrode interface are built.
More accurate or representative equivalent circuit models might
improve the utility of impedance monitoring to accurately deduce
the progression of the reactive tissue response.
Our study further demonstrates that treating electrodes with
a PEG film via dip coating prior to immersion in a protein
solution negates these increases in impedance at physiologically
relevant frequencies. That electrodes pretreated with PEG exhibit
slight decreases in reactance supports our working hypothesis
that the PEG film forms a hydrated layer close to the electrode
surface that prevents proteins from accessing the surface of the
electrode, while simultaneously avoiding detrimental effects on
charge transfer at the electrode-electrolyte layer.
For the acute in vivo study, a two-electrode setup was used due
to the difficulty of implementing a three-electrode setup within
a surgical setting. The use of a two-electrode setup means that
the impedance of the tissue/electrode interface and the impedance
of the tissue are lumped into a single impedance source. The
expected contribution of the tissue impedance component is
confirmed by the considerable increase observed in both the
resistance and capacitance following the insertion of the electrode
into the rat brain. For this study, we wanted to examine the contri-
bution of non-cellular components to the change in impedance,
and therefore chose a short time scale during which no tissue
remodeling occurs. Since cellular responses in the brain following
electrode implantation are not observed until several hours post
implantation (Kozai et al., 2012), our impedance measurement
needed to be conducted within that time frame. We chose an arbi-
trary time point of 5 min post-insertion to minimize the exposure
of the animals to unnecessary anesthesia, but it is possible for
impedance changes to be time sensitive.
The application of an aqueous solution of a higher molecular
weight PEG by dip-coating onto the microelectrode and directly
into the craniotomy resulted in a reduction in the magnitude of
the increase from the in vitro baseline impedance. Because the tis-
sue impedance component is presumed not to change within this
short time frame, we can assume that the difference in impedance
with PEG treatment compared to the no treatment condition is
due primarily to the modulation of the electrode/tissue interface
impedance component. In the control craniotomy, we posit that a
considerable portion of the immediate impedance increase comes
from hydrophobic biomolecules that come into contact with the
electrode surface and hinder charge transfer. The application
Frontiers in Neuroengineering www.frontiersin.org August 2014 | Volume 7 | Article 33 | 6
Sommakia et al. Acute impedance change mitigation with PEG
of free-floating high molecular weight PEG appears to confer
some degree of protection from the effects of aforementioned
biomolecules, and results in lower impedance. With this simple
method of applying PEG via dip-coating, there are concerns about
the uniformity of coatings between electrodes. While we did not
directly quantify the morphology of our dip-coated PEG films,
we did attempt to control the deposition process to minimize
variability. Since the dip-coating velocity is a major contributing
factor to the uniformity of dip-coated films (Scriven, 1988), we
controlled our dip-coating velocity by using a micromanipula-
tor. Because we did observe statistically significant changes in
impedance in response to our dip coatings, we did not make
further attempts to identify and reduce individual contributors
to inter-electrode variations.
Much more research needs to be conducted into the use of PEG
to understand its potential long-term effects on the functional
longevity of implantable intracortical microelectrodes. While
prior research in the field has found that conformal microgel
PEG coatings that do prevent cellular adhesion in vitro do not
result in significant improvement to the cellular composition of
the chronic electrode tissue interface (Gutowski et al., 2014), the
effects of such PEG-containing coatings on the electrical proper-
ties of functional electrodes have not been tested. It is possible that
significant protective effects using grafted coatings have not been
observed due to the use of lower molecular weights. For our proof
of concept demonstration for PEG, we used a molecular weight
of 4000 Da, which has been shown to be optimal for reducing
biofouling in comparison with lower molecular weights (Su et al.,
2009). With biopolymers, there are concerns about degradability
which might limit the long-term potential for such coatings to
modulate the reactive tissue response. PEG, however, is generally
not considered easily degradable in physiological conditions, and
degradable PEG hydrogels generally need to be engineered with
special cleavage sites to facilitate biodegradability (Drury and
Mooney, 2003). On the other hand, the effects of long-term
presence of large polymeric molecules in the brain should be
considered before employing such molecules as neurointegrative
coatings.
These complex considerations surrounding such antifouling
coatings present an attractive research area. While chemically
immobilized coatings are a commonplace choice for neuroin-
tegrative coatings, there might be additional merits to weakly
attached PEG films. For example, intravenous treatment with
higher molecular weight PEG has been shown to improve cellular
and behavioral recovery in traumatic brain injury (Koob et al.,
2005, 2008; Koob and Borgens, 2006), due to its fusogen proper-
ties which allow it to induce membrane sealing of damaged cells
and tissue (Shi, 2013). It is possible that these properties of higher
molecular weight PEG can be similarly effective in disrupting
deposition of proteins and other molecules at the electrode vicin-
ity, in addition to mitigating chronic blood-brain barrier damage,
a major factor in chronic device failure (Saxena et al., 2013).
Before dip-coated PEG films can be prescribed as a long-term
solution for preventing the reactive tissue response and increase
the functional longevity of implantable neural microelectrodes,
more extensive parametric studies need to be conducted. These
studies should consider the molecular weight of the PEG used, in
addition to the morphological characteristics of the applied films,
such as roughness and thickness, and related properties such as
degradation kinetics. The delivery method of PEG films is also an
open question. It might be necessary to combine multiple delivery
methods; for example, concurrently immobilizing PEG onto the
electrode surface and applying free-floating PEG. One potential
approach under investigation is the use of thin-film silica sol-
gel coatings, which have the potential to incorporate released
and immobilized molecules, and do not adversely affect electrical
properties (Pierce et al., 2009). Such future experiments with PEG
should combine impedance monitoring with histological analysis
of the reactive tissue response on a chronic time scale. Our find-
ings provide a first step by highlighting the potential contribution
of non-cellular molecular components to impedance changes, and
offer a proof of concept for dip-coated PEG films as a potential
component within a holistic neurointegrative strategy.
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